Tag Archives: Vetanco
INCUINTA and Bioinnovo apply their knowledge to fight COVID19
Argentine researchers used two different platforms to neutralize the virus with “nanobodies” derived from llamas [...]
Nov
Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus
Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]
Nov
A new achievement in the fight against COVID-19
A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 [...]
Oct
Vetanco and Bioinnovo congratulate the company Algenex on a new achievement
Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, [...]
Sep
Bovine Viral Diarrhea: the Argentinian vaccine will be sold in Peru
The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control [...]
Aug
100% Argentinian technology for the COVID-19 test
Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an [...]
Aug
Vetanco develops an alliance with the UDESC
The constant Research and Development is a principle of Vetanco DNA and the reason why [...]
Aug
Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020
Due to the rising interest in Biotech Vac. Technology, Sherry Layton, Chief Scientific Officer of [...]
Jul
Pig farming situation in the USA
What follows is a general outlook of the reality that pig farming in the United [...]
Jun
Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis
Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted [...]
Jun